D. Medical Rises Most in Two Weeks on Potential Acquisition
D. Medical Industries Ltd. (DMED) rose the most in almost two weeks after the maker of drug delivery devices said it is negotiating a potential acquisition of a diabetes devices company.
The shares surged 7.9 percent, the most since June 7, to 1.605 shekels, at 4:05 p.m. in Tel Aviv, lifting the company’s market value to 17.4 million shekels ($4.5 million).
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.